Treating Binge Eating Disorder With Magic Mushrooms: Phase 2 Clinical Trial Gets Thumbs Up – Tryp Therapeutics (OTC:TRYPF)
[ad_1] Clinical-stage psychedelics biotech Tryp Therapeutics, Inc. TRYPF shared the interim results for the first five patients dosed in its Phase 2 STOP (Study of the Treatment of Overeating utilizing…
Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS’ 2nd Phase 3 Trial
[ad_1] MAPS Public Benefit Corporation (MAPS PBC), the non-profit’s private biopharma leg developing psychedelic medicines, announced positive results from MAPP2, the company’s second Phase 3 study assessing MDMA-assisted therapy for…
Kevin McCarthy on track to lose 11th Speaker vote despite concessions
[ad_1] Republican congressman Kevin McCarthy was on track to lose a historic 11th round of voting in his bid to become Speaker of the House on Thursday night, after his…
South Carolina’s New Year Could Bring Medical Cannabis Dispensaries, Lawmakers Pre-File New Bills
[ad_1] Lawmakers in South Carolina’s House pre-filed two bills for the 2023 legislative session to legalize medical marijuana. If one of the bills gains momentum the Palmetto state could join…
Cannabis MSOs Using Tax Liability Loopholes To Fund Operations, Which Ones Top This Analyst’s List? – Curaleaf Holdings (OTC:CURLF), 4Front Ventures (OTC:FFNTF)
[ad_1] Federal prohibition makes it difficult for a cannabis business to operate fair and square. Not only is it depriving them from access to the financial system, but it also…